Intraenous atrial natriuretic peptide ( anp ) improes cardiac sympathetic nere actiity ( csna ) and preents left entricular ( l ) remodeling in patients with first anterior acute myocardial infarction ( ami ) , japanese researchers reeal 日本研究人员揭示，静脉内注射心房利钠肽（ anp ）可以改善心脏交感神经活性（ csna ）并预防首发前壁心肌梗死（ mi ）患者左室重塑。
Patients with above - median mpo levels in combination with above - median plasma amino - terminal pro - brain natriuretic peptide ( nt - probnp ) or below - median left ventricular ejection fraction ( lvef ) had significantly greater mortality compared with other patients 在mpo中位数以上水平伴血浆氨基末端前脑利钠肽中位数水平以上病人或左心室射血分数在中位数以下病人相对于其他病人有更高的死亡率。
Conclusion despite an initial reduction in plasma b - type natriuretic peptide level in patients in the levosimendan group compared with patients in the dobutamine group , levosimendan did not significantly reduce all - cause mortality at 180 days or affect any secondary clinical outcomes 结论：尽管和多巴酚丁胺组相比，左西孟旦组能降低病人初期血浆b型利钠肽水平，但是左西孟旦并不能显著地降低180天所有原因死亡率或其他任何次级观察结果。
Vasonatrin peptide ( vnp ) is a man - made new member of natriuretic peptide family . previous studies have demonstrated that vnp was effective in preventing and treating hypoxic pulmonary hypertension and right ventricular hypertrophy , and inhibiting the proliferation of pulmonary artery smooth muscle cells 血管钠肽( vasonatrinpeptide , vnp )是人工合成的钠尿肽家族新成员，研究表明vnp能防治低氧条件下大鼠肺动脉高压和右心室肥厚的形成，并能抑制肺动脉平滑肌细胞的增殖。
